Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Fortrea Holdings Inc. (FTRE) vs Zymeworks Inc. (ZYME)

Fortrea Holdings Inc. and Zymeworks Inc. are both Biotechnology companies. Fortrea Holdings Inc. and Zymeworks Inc. are of similar size ($1.9B and $1.9B). Fortrea Holdings Inc. grew revenue faster over the last twelve months: −2.09% against −69.8%. Fortrea Holdings Inc. has the higher net margin (−3.18% vs −404.0%) and the lower return on invested capital (−0.48% vs 0.00%). Across the 18 metrics below, Fortrea Holdings Inc. leads on 12 and Zymeworks Inc. on 6.

Valuation

Metric FTRE ZYME Biotechnology median
P/E n/m n/m 7.88
P/S 0.70 52.14 11.47
P/B 3.60 24.09 2.52
Price to free cash flow 9.52 n/m 21.16
EV/EBITDA 41.06 n/m 0.74
EV/Sales 1.04 44.86 10.73
Earnings yield (4.58%) (7.62%) (28.84%)
Free cash flow yield 10.50% (6.27%) (23.03%)

Profitability

Metric FTRE ZYME Biotechnology median
Gross margin 19.30% (246.66%) 65.16%
Operating margin (0.40%) (418.99%) 0.00%
Net margin (3.18%) (404.00%) 0.00%
Free cash flow margin 7.40% (324.68%) 0.00%
Return on equity (15.30%) (72.31%) (57.72%)
Return on assets (3.07%) (37.25%) (49.22%)
Return on invested capital (0.48%) 0.00% 0.00%

Growth

Metric FTRE ZYME Biotechnology median
Revenue growth (TTM) (2.09%) (69.78%) 5.64%
EPS growth (last fiscal year) (194.55%) 33.33% —
Revenue growth, 5-year CAGR 1.09% 22.16% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric FTRE ZYME Biotechnology median
Debt to equity 2.01 0.00 0.00
Current ratio 0.96 6.32 4.73
Net debt to EBITDA 266.13 2.81 0.96

Dividend

Metric FTRE ZYME Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric FTRE ZYME Biotechnology median
Market cap 1.90b 1.92b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack